Skip to main content
SpringerLink
Log in

Uterine adenocarcinoma after GnRH agonist treatment

  • Case report
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract 

We report endometrial adenocarcinoma in two patients shortly after suspending GnRH-agonist treatment for menometrorrhagia and uterine fibromata.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Viale S. Pietro 12, 07100 Sassari, Italy Tel.: +39-79-228260, Fax: +39-79-228265, , , , , , IT

    S. Dessole, G. A. Ruiu, P. L. Cherchi & G. Ambrosini

Authors
  1. S. Dessole
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. A. Ruiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. L. Cherchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Ambrosini
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 26 March 1999 / Accepted: 17 July 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dessole, S., Ruiu, G., Cherchi, P. et al. Uterine adenocarcinoma after GnRH agonist treatment. Arch Gynecol Obstet 263, 148–149 (2000). https://doi.org/10.1007/PL00007473

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007473

Search

Navigation